Colorectal cancer

In Switzerland, approximately 4,500 new cases of colorectal cancer are diagnosed each year, with a troubling trend showing that younger individuals under 50 are increasingly affected. This rise in cases contrasts sharply with the decline in colorectal cancer among those over 50, attributed largely to effective screening programs.

Currently, cancers occurring before age 50 represent 6.1% of all colorectal cancer cases. More concerning is the steady increase in incidence among this younger demographic, which has risen by approximately 0.5% annually. As a result, the incidence rate for colorectal cancer in individuals under 50 has reached nearly 7 cases per 100,000 person-years.

Colorectal cancer has now become the leading cause of cancer-related deaths among people under 50, despite overall declining death rates in older age groups. Experts point to several contributing factors for this alarming trend.

Key contributing factors:

• Genetics play a significant role; about 20% of patients have hereditary markers linked to colorectal cancers.
• Environmental factors—including dietary changes and lifestyle modifications—are suspected to contribute to the rising incidence.
• Healthcare professionals report cases emerging in individuals as young as their thirties who have no personal or family history of the disease.

Dr. Jeremy Meyer noted that “cases are now emerging in people in their thirties, with no personal or family history of the disease.” Despite aggressive treatments such as increased chemotherapy or surgery for younger patients, outcomes have not necessarily improved. Ning Jin stated that “even though we treat young patients with more aggressive chemo—more chemo or more surgery—patients’ outcomes are not necessarily better.”

The medical community is increasingly focused on understanding the role of the gut microbiome and other factors influencing colorectal cancer’s rise among young adults. Dr. John Marshall reflected on his experience: “Thirty-plus years ago, when I first started, no one—no one; zero number of patients—were in my clinic under the age of 50 with colon cancer.” This stark contrast highlights a significant shift in how colorectal cancer affects younger populations today.